1. Home
  2. FGF vs ICCM Comparison

FGF vs ICCM Comparison

Compare FGF & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGF
  • ICCM
  • Stock Information
  • Founded
  • FGF 2012
  • ICCM 2006
  • Country
  • FGF United States
  • ICCM Israel
  • Employees
  • FGF N/A
  • ICCM N/A
  • Industry
  • FGF Property-Casualty Insurers
  • ICCM
  • Sector
  • FGF Finance
  • ICCM
  • Exchange
  • FGF Nasdaq
  • ICCM Nasdaq
  • Market Cap
  • FGF 28.0M
  • ICCM 29.3M
  • IPO Year
  • FGF N/A
  • ICCM N/A
  • Fundamental
  • Price
  • FGF $31.15
  • ICCM $0.61
  • Analyst Decision
  • FGF
  • ICCM Strong Buy
  • Analyst Count
  • FGF 0
  • ICCM 2
  • Target Price
  • FGF N/A
  • ICCM $2.70
  • AVG Volume (30 Days)
  • FGF 40.6K
  • ICCM 1.2M
  • Earning Date
  • FGF 11-14-2024
  • ICCM 11-26-2024
  • Dividend Yield
  • FGF N/A
  • ICCM N/A
  • EPS Growth
  • FGF N/A
  • ICCM N/A
  • EPS
  • FGF N/A
  • ICCM N/A
  • Revenue
  • FGF N/A
  • ICCM $3,336,000.00
  • Revenue This Year
  • FGF N/A
  • ICCM $18.61
  • Revenue Next Year
  • FGF N/A
  • ICCM $54.91
  • P/E Ratio
  • FGF N/A
  • ICCM N/A
  • Revenue Growth
  • FGF 52.56
  • ICCM 3.60
  • 52 Week Low
  • FGF $14.21
  • ICCM $0.48
  • 52 Week High
  • FGF $44.00
  • ICCM $1.57
  • Technical
  • Relative Strength Index (RSI)
  • FGF 66.31
  • ICCM 44.82
  • Support Level
  • FGF $16.25
  • ICCM $0.53
  • Resistance Level
  • FGF $18.67
  • ICCM $0.64
  • Average True Range (ATR)
  • FGF 3.34
  • ICCM 0.10
  • MACD
  • FGF 1.03
  • ICCM -0.02
  • Stochastic Oscillator
  • FGF 92.62
  • ICCM 20.05

About FGF FG Financial Group Inc. (NV)

Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segment includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: